Enhanced Cell-mediated Tumor Killing in Patients Immunized with Human Monoclonal Antiidiotypic Antibody 105AD7

Cancer Research

Volumn 54, Issue 18, 1994, Pages 4837-4840

  Dun ant, L G ^a   Buckley, T J D ^a   Denton, G W L ^a   Hardcastle, J D ^a   Sewell, H F ^b   Robins, R A ^b  

^a Plastic Surgery   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IDIOTYPIC ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 105AD7; UNCLASSIFIED DRUG;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNIZATION; CELL MEDIATED CYTOTOXICITY; CLINICAL ARTICLE; CYTOTOXICITY TEST; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; RECTUM CANCER;

AGED; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL; FEMALE; HUMAN; IMMUNITY, CELLULAR; IMMUNIZATION; KILLER CELLS, NATURAL; MALE; MIDDLE AGE; RECTAL NEOPLASMS; SUPPORT, NON-U.S. GOV'T; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 0028146963     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Austin, E. B., Robins, R. A., Durrani, L. G., Price, M. R., and Baldwin, R. W. Human monoclonal anti-idiotypic antibody to the tumor associated antibody 791T/36. Immunology, 67: 525-530, 1989.
2. Austin, E. B., Robins, R. A., Baldwin, R. W., and Durrant, L. G. Induction of delayed hypersensitivity to human tumor cells with a human monoclonal and idiotypic antibody. J. Natl. Cancer Inst. 83: 1245-1248, 1991.
3. Robins, R. A., Denton, G.W.L. Hardcastle, J. D., Austin, E. B., Baldwin, R. W., and Durrant, L. G. Anti-tumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal antiidiotypic antibody. Cancer Res. 51: 5425-5429, 1991.
4. Denton, G.W.L. Durrant, L. G., Hardcastle, J. D., Austin, E. B., Sewell, H. F., and Robins, R. A. Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody. Int. J. Cancer, 57: 10-14, 1994.
5. Working Party on the Clinical Use of Antibodies. Operation manual for control of production, preclinical toxicology and phase 1 trials of anti-tumour antibodies and drug antibody conjugates. Br. J. Cancer, 54: 557-568, 1986.
6. Durrant, L. G., Robins, R. A., Armitage, N. C., Brown, A., Baldwin, R. W., and Hardcastle, J. D. Association of antigen expression and DNA ploidy in colorectal tumors. Cancer Res. 46: 533-537, 1986.
7. Pross, H. F., Baines, M. G., Rubin, P., Shragge, P., and Patterson, M. S. Spontaneous human lymphocyte mediated cytotoxicity against target tumor cells. IX The quantitation of natural killer cell activity. J. Clin. Immunol. /; 51-63, 1981.
8. G. Moller (ed.). T-cell activation. Immunol. Rev. 111, 1989.
9. O'Rouke, A. M., and Mescher, M. F. Cytotoxic lymphocyte T activation involves a cascade of signalling and adhesion events. Nature (Lond.), 358: 253-256, 1992.
10. Townsend, A., and Bodmer, H. Antigen recognition by class-I restricted lympho-cyte-T. Annu. Rev. Immunol. 7: 601-624.
11. Bjorkma, P. J., Saper, M. A., Samaouri, B., Bennet, W. S., Strominger, J. L., and Wiley, D. C. The foreign antigen binding site and T-cell recognition of class-I histocompatibility antigens. Nature (Lond.), 329: 512-518, 1987.
12. Yewdell, J. W., and Bennink, J. R. Cell biology of antigen processing and presentation to major histocompatibility antigens. Adv. Immunol. 52: 1-123, 1992.
13. Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B., and Rock, K. L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA, 90: 4942-4946, 1993.
14. +ve cytotoxic T-cells by immunization with purified HIV-I envelope protein in ISCOMs. Nature (Lond.), 244: 873-875, 1990.
15. Reddy, R., Zhou, F., Niar, S., Huang, L., and Barry, B. T. In vivo cytotoxic lymphocyte-T induction with soluble proteins administered in liposomes. J. Immunol. 148: 3336-3341, 1992.
16. Collins, D. S., Findlay, K., and Harding, C. V. Processing of exogenous liposome encapsulated antigens in vivo generates class-I MHC restricted T-cell responses. J. Immunol. 750: 1244-1252, 1993.
17. Stuhler, G., and Walden, P. Collaboration of helper and cytotoxic T-lymphocytes. Eur. J. Immunol. 23: 2279-2286, 1993.